<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[USA-udmelding om &quot;meget stor told på medicin&quot;]]></title><description><![CDATA[<p dir="auto">Trump har været ude med en meget bombastisk melding om told på medicin. Det har sat sig hårdt i markedet, hvor aktierne i medicinalindustrien over en bred kam faldt. Det er sågar smittet af på biotekselskaberne. Hvad sker der nu? Vil medicinproduktionen strømme til USA? Og hvordan rammer det f.eks. Novo Nordisk? Til sidst kommer Helge Larsen ind på Zealand Pharma og et interview, som Per Hansen har lavet med CEO Adam Steensberg.</p>
<p dir="auto">Denne video er ikke en anbefaling om køb eller salg af aktier. Helge Larsen har aktier i Novo Nordisk, Zealand Pharma og Eli Lilly.</p>
<p dir="auto"></p><div class="ratio ratio-16x9">
<iframe src="https://www.youtube-nocookie.com/embed/9l6IWdZgaDg" title="YouTube video player" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen"></iframe>
</div><p></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/447225/usa-udmelding-om-meget-stor-told-p-medicin</link><generator>RSS for Node</generator><lastBuildDate>Sat, 13 Jun 2026 13:07:26 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/447225.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 17 Apr 2025 11:17:22 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to USA-udmelding om &quot;meget stor told på medicin&quot; on Fri, 18 Apr 2025 04:35:31 GMT]]></title><description><![CDATA[<p dir="auto">European pharma companies issue demands to stay in EU ahead of expected US tariffs</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.reuters.com/sustainability/boards-policy-regulation/european-pharma-companies-issue-demands-stay-eu-ahead-expected-us-tariffs-2025-04-15/">
reuters.com
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.reuters.com/sustainability/boards-policy-regulation/european-pharma-companies-issue-demands-stay-eu-ahead-expected-us-tariffs-2025-04-15/" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.reuters.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.reuters.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9492641</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9492641</guid><dc:creator><![CDATA[B.Andersen]]></dc:creator><pubDate>Fri, 18 Apr 2025 04:35:31 GMT</pubDate></item><item><title><![CDATA[Reply to USA-udmelding om &quot;meget stor told på medicin&quot; on Fri, 18 Apr 2025 04:09:05 GMT]]></title><description><![CDATA[<p dir="auto">Shares in Eli Lilly jumped as much as 14% on Thursday after the company announced positive Phase III results for its oral GLP-1 drug orforglipron in adults with type 2 diabetes. In the ACHIEVE-1 study, the small molecule was associated with significant reductions in blood glucose versus placebo, as well as promising weight loss</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://firstwordpharma.com/story/5950404">
Just a moment...
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://firstwordpharma.com/story/5950404" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://firstwordpharma.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(firstwordpharma.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9492639</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9492639</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 18 Apr 2025 04:09:05 GMT</pubDate></item><item><title><![CDATA[Reply to USA-udmelding om &quot;meget stor told på medicin&quot; on Thu, 17 Apr 2025 18:37:52 GMT]]></title><description><![CDATA[<p dir="auto">pauly Ja, det virker lidt voldsomt. Novo handles til en kurs, der indikerer manglende tillid til indtjeningen 10 år fra nu. I forhold til forventet indtjening i 2027 er den i hvert fald alt alt for billig. Så kan man til gengæld glæde sig over, at de har mulighed for at købe egne aktier til en god pris set med nutidsbriller.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9492644</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9492644</guid><dc:creator><![CDATA[bb8]]></dc:creator><pubDate>Thu, 17 Apr 2025 18:37:52 GMT</pubDate></item><item><title><![CDATA[Reply to USA-udmelding om &quot;meget stor told på medicin&quot; on Thu, 17 Apr 2025 18:03:57 GMT]]></title><description><![CDATA[<p dir="auto">NOVO skulle der stå</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9492635</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9492635</guid><dc:creator><![CDATA[Thunderbolt52]]></dc:creator><pubDate>Thu, 17 Apr 2025 18:03:57 GMT</pubDate></item><item><title><![CDATA[Reply to USA-udmelding om &quot;meget stor told på medicin&quot; on Thu, 17 Apr 2025 18:02:12 GMT]]></title><description><![CDATA[<p dir="auto">8% vægttab for højeste dosis lyder da ikke så fantastisk, men det må det jo være?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9492640</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9492640</guid><dc:creator><![CDATA[pauly]]></dc:creator><pubDate>Thu, 17 Apr 2025 18:02:12 GMT</pubDate></item><item><title><![CDATA[Reply to USA-udmelding om &quot;meget stor told på medicin&quot; on Thu, 17 Apr 2025 15:54:01 GMT]]></title><description><![CDATA[<p dir="auto">I lige måde god påske til dig.</p>
<p dir="auto">I forhold til amyloidose er petrelintide fra Zealand Pharma designet til at undgå dannelse af amyloidfibriller, hvilket reducerer risikoen for at bidrage til amyloidose, i modsætning til naturligt amylin, som kan danne sådanne fibriller under visse betingelser, f.eks. ved type 2-diabetes.</p>
<p dir="auto">Det samme gælder Novo Nordisks amylinanaloger cagrilintide og NN1213, som også er kunstige (syntetiske) molekyler lige som petrelintide.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9492633</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9492633</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 17 Apr 2025 15:54:01 GMT</pubDate></item><item><title><![CDATA[Reply to USA-udmelding om &quot;meget stor told på medicin&quot; on Thu, 17 Apr 2025 14:55:39 GMT]]></title><description><![CDATA[<p dir="auto">Ja og Nono falder lige nu 8 % i USA pga Eli Lillys nyeste data ..øv</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9492638</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9492638</guid><dc:creator><![CDATA[Thunderbolt52]]></dc:creator><pubDate>Thu, 17 Apr 2025 14:55:39 GMT</pubDate></item><item><title><![CDATA[Reply to USA-udmelding om &quot;meget stor told på medicin&quot; on Thu, 17 Apr 2025 14:07:49 GMT]]></title><description><![CDATA[<p dir="auto">God Påske til dig Helge! Lige en lille spike mht. Amylin! :<a href="https://ugeskriftet.dk/videnskab/amyloidose-er-en-sygdom-med-mange-ansigter" rel="nofollow ugc">https://ugeskriftet.dk/videnskab/amyloidose-er-en-sygdom-med-mange-ansigter</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9492634</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9492634</guid><dc:creator><![CDATA[deleted-user]]></dc:creator><pubDate>Thu, 17 Apr 2025 14:07:49 GMT</pubDate></item></channel></rss>